Single-center, Randomized, Double-blind, 2-treatment, 2-period Crossover Trial in Healthy Subjects to Demonstrate PK Bioequivalence and to Compare the PD Properties of Julphar Insulin N and Huminsulin Basal
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 07 Mar 2018
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Julphar Gulf Pharmaceutical Industries
- 02 Mar 2018 Planned End Date changed from 30 Oct 2017 to 30 Apr 2018.
- 02 Mar 2018 Planned primary completion date changed from 30 Oct 2017 to 30 Apr 2018.
- 24 Jul 2017 Planned End Date changed from 10 Feb 2017 to 30 Oct 2017.